Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Cookson (London, United Kingdom). Genes, mechanisms and new therapies for asthma. Lung Science Conference 2010 - Biology of gene-environment interactions in the lung

Member's Comments

No comment yet.

Related content which might interest you: Genes, intervention and molecular mechanisms in COPD Source: Annual Congress 2007 - Physiological year in review Year: 2007 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Airway inflammation in asthma: current and future targets and therapies Source: Breathe 2010; 6: 245-252 Year: 2010 Translating mechanisms to new drugs for COPD exacerbations Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD” Year: 2009 New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology Year: 2005 New mechanisms and targets in COPD Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 The mechanisms of anti-inflammatory action of bronchodilators Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Biological and therapeutic implications of the united airways disease concept Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005 Do we need new therapies for noneosinophilic asthma? Source: Annual Congress 2004 - Noneosinophilic asthma Year: 2004 Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016 Year: 2017 Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials? Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players? Year: 2019 Identification of molecular pathways in distinct asthma phenotypes identified in ADEPT Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Exploitation of anti-inflammatory mechanisms for the treatment of severe asthma Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005